Clinical trial · Interventional
Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype
NCT02387177CI-TRIAL-00034410completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this research is to adapt the NF-specific adult version of the Skype 3RP for use with adolescents, and to test its feasibility, acceptability, and preliminary effect in improving quality of life, and in decreasing stress and psychological distress.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neurofibromatoses | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Stress Management Group 1 | Behavioral | — | UNRESOLVED |
| Stress Management Group 2 | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Stress Management Group 1
- description
- Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.
- interventionNames
- Behavioral: Stress Management Group 1
- type
- EXPERIMENTAL
- label
- Stress Management Group 2
- description
- Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.
- interventionNames
- Behavioral: Stress Management Group 2
Primary outcomes (1)
- measure
- Quality of life (WHO-QOLBREFadol)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 12 Years
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: 1. Must be between the ages of 12 and 17 2. Can read and speak English at or above the 6th grade level 3. Diagnosis of neurofibromatosis type 1 or neurofibromatosis type 2 by a specialized medical provider Exclusion Criteria: 1. Severe active or untreated major mental illness that would interfere with study participation, to be determined at the discretion of the study investigator (e.g. untreated psychosis or suicidality) 2. Recent (within past 3 months) change in antidepressant medication 3. Use of formal relaxation training (including past participation in a mind-body program), currently or in the past 6 months 4. Unable or unwilling to sign the informed consent documents 5. Unable or unwilling to participate in an intervention delivered via videoconferencing with Skype
References
Publications (0)
Data not yet available
No reference posted for this study.